Fecal Microbiota Transplant (FMT)

Transfer of healthy donor stool to restore gut microbiome diversity and function.

Evidence Score

82/100

Developer

Various (emerging therapy)

Duration

Single procedure or series over weeks, effects may last months to years

Steps

10 phases

Conditions

4 targeted

Protocol Overview

Transfer of healthy donor stool to restore gut microbiome diversity and function. FDA-approved for recurrent C. diff, experimental for other conditions. Can be done via colonoscopy, endoscopy, enema, or oral capsules.

Conditions Treated

C. difficile infectionulcerative colitisIBSautism (experimental)

Crohn's Disease / Ulcerative Colitis (IBD) →Autism Spectrum (Biomedical Approaches) →

Key Resources

OpenBiome (commercial supplier), research centers, DIY protocols (risky), clinical trials

Safety Profile

Contraindications & Risks

Immunocompromised patients (risk of infection), IBD with active severe inflammation, improper donor screening can transmit disease

Important Notes

FDA-approved specifically for recurrent C. diff after 2021. Highly effective for C. diff. Experimental but promising for UC, IBS. Autism studies mixed. DIY has risks. Screen donors extensively. Future of microbiome medicine.

Find a Practitioner

Connect with practitioners experienced in this protocol.

Browse Practitioners

EvidenceLow-Moderate

Evidence Score82/100

Categorygut

DurationSingle procedure or series over weeks, effects may last months to years

About Evidence Score

The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.

Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.